Orthofix Medical Inc (OFIX)
18.68
-0.19
(-1.01%)
USD |
NASDAQ |
Nov 21, 16:00
18.72
+0.04
(+0.21%)
After-Hours: 20:00
Orthofix Medical Enterprise Value: 802.25M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 802.25M |
| November 20, 2024 | 809.51M |
| November 19, 2024 | 804.16M |
| November 18, 2024 | 787.35M |
| November 15, 2024 | 779.32M |
| November 14, 2024 | 760.98M |
| November 13, 2024 | 800.72M |
| November 12, 2024 | 824.03M |
| November 11, 2024 | 853.46M |
| November 08, 2024 | 830.15M |
| November 07, 2024 | 784.67M |
| November 06, 2024 | 791.55M |
| November 05, 2024 | 765.18M |
| November 04, 2024 | 750.66M |
| November 01, 2024 | 736.52M |
| October 31, 2024 | 707.01M |
| October 30, 2024 | 713.13M |
| October 29, 2024 | 713.51M |
| October 28, 2024 | 706.63M |
| October 25, 2024 | 695.17M |
| October 24, 2024 | 691.73M |
| October 23, 2024 | 687.15M |
| October 22, 2024 | 700.90M |
| October 21, 2024 | 707.40M |
| October 18, 2024 | 701.67M |
| Date | Value |
|---|---|
| October 17, 2024 | 695.55M |
| October 16, 2024 | 700.52M |
| October 15, 2024 | 686.76M |
| October 14, 2024 | 703.58M |
| October 11, 2024 | 683.71M |
| October 10, 2024 | 661.55M |
| October 09, 2024 | 664.60M |
| October 08, 2024 | 665.37M |
| October 07, 2024 | 664.98M |
| October 04, 2024 | 672.63M |
| October 03, 2024 | 671.10M |
| October 02, 2024 | 682.56M |
| October 01, 2024 | 672.63M |
| September 30, 2024 | 685.24M |
| September 27, 2024 | 676.47M |
| September 26, 2024 | 678.77M |
| September 25, 2024 | 679.15M |
| September 24, 2024 | 687.55M |
| September 23, 2024 | 699.00M |
| September 20, 2024 | 710.45M |
| September 19, 2024 | 713.89M |
| September 18, 2024 | 707.78M |
| September 17, 2024 | 710.83M |
| September 16, 2024 | 722.67M |
| September 13, 2024 | 731.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
235.04M
Minimum
Oct 24 2022
853.46M
Maximum
Nov 11 2024
600.88M
Average
604.39M
Median
Mar 28 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| InfuSystems Holdings Inc | 224.07M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.39M |
| Revenue (Quarterly) | 196.61M |
| Total Expenses (Quarterly) | 213.54M |
| EPS Diluted (Quarterly) | -0.71 |
| Gross Profit Margin (Quarterly) | 68.69% |
| Profit Margin (Quarterly) | -13.93% |
| Earnings Yield | -16.76% |
| Normalized Earnings Yield | -15.03 |